XWELL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.8 USD | +26.76% |
|
+29.50% | +3.45% |
| Apr. 16 | XWELL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 16 | Transcript : XWELL, Inc., 2023 Earnings Call, Apr 16, 2024 |
Financials (USD)
| Sales 2022 | 55.94M | Sales 2023 | 30.11M | Capitalization | 7.27M |
|---|---|---|---|---|---|
| Net income 2022 | -32M | Net income 2023 | -27M | EV / Sales 2022 | 0.04 x |
| Net cash position 2022 | 28.08M | Net cash position 2023 | 11.96M | EV / Sales 2023 | -0.16 x |
| P/E ratio 2022 |
-1.04
x | P/E ratio 2023 |
-0.26
x | Employees | 302 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.95% |
More Fundamentals
* Assessed data
More news
Latest transcript on XWELL, Inc.
More recommendations
More press releases
| 1 day | +26.76% | ||
| 1 week | +29.50% | ||
| Current month | +6.51% | ||
| 1 month | -3.23% | ||
| 3 months | +23.36% | ||
| 6 months | -5.76% | ||
| Current year | +3.45% |
1 week
1.32
1.82
1 month
1.321.85
Current year
1.262.22
1 year
1.266.40
3 years
1.2643.80
5 years
1.26327.00
10 years
1.2651 240.02
| Managers | Title | Age | Since |
|---|---|---|---|
Scott Milford
CEO | Chief Executive Officer | 59 | 19-07-14 |
Suzanne Scrabis
DFI | Director of Finance/CFO | 54 | 23-07-09 |
Ezra Ernst
PRN | Corporate Officer/Principal | - | 21-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Scott Milford
CEO | Chief Executive Officer | 59 | 19-07-14 |
Robert Weinstein
BRD | Director/Board Member | 64 | 20-02-02 |
Bruce Bernstein
CHM | Chairman | 60 | 16-02-07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 1.8 | +26.76% | 33,829 |
| 24-04-23 | 1.42 | +5.19% | 13,305 |
| 24-04-22 | 1.35 | -2.17% | 11,836 |
| 24-04-19 | 1.38 | -1.43% | 4,414 |
| 24-04-18 | 1.4 | +0.72% | 4,441 |
Delayed Quote Nasdaq, April 24, 2024 at 04:30 pm EDT
More quotes
XWELL, Inc. is a global health and wellness holding company. The Company operates through four segments: XpresTest, XpresSpa, Treat, and HyperPointe. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck wellness centers in airports, to airport employees and to the traveling public. Its Treat segment provides access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place, as well as book appointments in the Companyâs on-site wellness centers as they reopen. HyperPointe segment provides a range of service and support options for its customers, including technical support services and advanced services.
Sector
Personal Services
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +3.45% | 7.53M | |
| -14.72% | 563M | |
| +39.53% | 473M | |
| -28.18% | 393M | |
| +10.34% | 295M | |
| -25.86% | 194M | |
| -25.00% | 95.6M | |
| -3.55% | 82.41M | |
| -8.28% | 68.43M | |
| -23.77% | 63.06M |
- Stock Market
- Equities
- XWEL Stock
